doiSerbia

Antimycotics susceptibility testing of dermatophytes

Arsić-Arsenijević Valentina (Referentna laboratorija za uzročnike mikoza, Institut za mikrobiologiju i imunologiju, Medicinski fakultet, Beograd)
Branković Milena (Mikrobiološka laboratorija, Opšta bolnica, Užice)
Čolović Ivana (Referentna laboratorija za uzročnike mikoza, Institut za mikrobiologiju i imunologiju, Medicinski fakultet, Beograd)
Džamić Aleksandar (Referentna laboratorija za uzročnike mikoza, Institut za mikrobiologiju i imunologiju, Medicinski fakultet, Beograd)
Mitrović Sanja (Referentna laboratorija za uzročnike mikoza, Institut za mikrobiologiju i imunologiju, Medicinski fakultet, Beograd)
Ratkov Eleonora (Referentna laboratorija za uzročnike mikoza, Institut za mikrobiologiju i imunologiju, Medicinski fakultet, Beograd)

Dermatophytes are moulds that produce infections of the skin, hair and nails of humans and animals. The most common forms among these infections are onychomycosis and tinea pedis affecting 20% of world population. These infections are usually chronic. The treatment of dermatophytoses tends to be prolonged partly because available treatments are not very effective. Antifungal drug consumption and public health expenditure are high worldwide, as well as in Serbia. For adequate therapy, it is necessary to prove infection by isolation of dermatophytes and to test the antifungal susceptibility of isolates. Susceptibility testing is important for the resistance monitoring, epidemiological research and to compare in vitro activities of new antifungal agents. The diffusion and dilution methods of susceptibility tests are used, and technical issues of importance for the proper performance and interpretation of test results are published in the document E.DEF 9.1 (EUCAST) and M38-A2 (CLSI). The aim of our paper is to promptly inform the public about technical achievements in this area, as well as the new organization of laboratory for medical mycology in our country. The formation of laboratory networks coordinated by the National Reference Laboratory for the cause of mycosis need to enable interlaboratory studies and further standardization of methods for antifungal susceptibility testing of dermatophytes, reproducibility of tests and clinical correlation monitoring (MIK values and clinical outcome of dermatophytosis). The importance of the new organization is expected efficient improvement in the dermatophytosis therapy at home, better quality of patient's life and the reduction of the cost of treatment.

Keywords: dermatophytes, susceptibility testing, documents E.DEF 9.1 and M38-A2